Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Sense of Smell

Yehuda Shoenfeld, MD  |  Issue: April 2009  |  April 1, 2009

The patients with SLE that we examined using the smell test fared significantly worse than age- and sex-adjusted controls. The impaired smelling capacity correlated with the SLEDAI activity index and was more prominent among patients with CNS involvement.14 These results are in accord with recent anatomical observations, including MRI scans, showing that patients with SLE have a reduction in the size of their amygdala that correlates with the duration and activity of the disease.15,16

Being a clinician and a basic immunologist, I was very excited by each discovery. Yet, being skeptical, I was always surprised to see how much is known and already published in the literature, but ignored by the conservative physician world. I shared my findings with my neighbor (a “natural” healer). She smiled at me saying, “We’ve know this for years! And we’ve used it for years!”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

I will note that aromatherapy was far from my interest but, considering our results, I started to dwell into this field of complementary and alternative medicine. Like all other fields of alternative medicine, aromatherapy lacks many well-controlled, double-blind studies, although a few such studies exist (cited herein) and, in my research, we are dealing with chemicals (fragrance) and neuronal receptors. However, it seems that a more intensive research of the effects of lupus on olfaction may lead to the better understanding of neural disturbance in this disease and the development of new series of therapies that may involve using aromatherapy to improve mood.

Figure 3: The olfactory system is involved in physiological processes like mood, cognition, memory, and lucidity but also in pathological conditions with low smell capacity, such as multiple sclerosis, Parkinson disease, CNS-SLE, Alzheimer disease, and schizophrenia.
Figure 3: The olfactory system is involved in physiological processes like mood, cognition, memory, and lucidity but also in pathological conditions with low smell capacity, such as multiple sclerosis, Parkinson disease, CNS-SLE, Alzheimer disease, and schizophrenia.

Defects in smelling capabilities have already been reported in other autoimmune diseases such as multiple sclerosis and in other neurological diseases conditions including Parkinson’s and Alzheimer’s diseases.17-19 (See Figure 3, above.) The dampened smelling capability appears at the early stages of these diseases and may have a predictive value for ultimate outcome. Aberrant smell function also characterizes depressive women and can be ameliorated by exposing the patients to orange or lavender fragrances (i.e., aromatherapy).

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The 2004 Nobel Prize in Medicine was granted to Linda Buck and Richard Axel for research on odorant receptors and olfactory system organization, and for deciphering the 1,000 genes for odor (in humans, only 350 genes still function). This seminal research emphasized the diversity of smell options (especially if combined with memory and emotions) in comparison to other senses, such as taste or vision, which only have a few associated genes.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:ConditionsResearch RheumSystemic Lupus Erythematosus Tagged with:Basic researchDiagnosisSystemic lupus erythematosus

Related Articles

    7 Tools to Identify Depression

    August 1, 2014

    Why screening for depressive symptoms in patients with arthritis is needed

    ASIA: A New Way to Put the Puzzle Together

    June 13, 2011

    Autoimmune (autoinflammatory) syndrome induced by adjuvants provides a diagnostic framework for enigmatic conditions

    Laboratory Testing for Diagnosis, Management of Patients with Rheumatic Disease

    December 1, 2014

    A review of data on antinuclear antibodies and tests for rheumatoid arthritis

    Depression in Rheumatoid Arthritis

    November 1, 2012

    Examining the psychological and health-related comorbidities of rheumatoid arthritis patients with depression

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences